Possible role of valvular serotonin 5-HT(2B) receptors in the cardiopathy associated with fenfluramine.

Dexfenfluramine was approved in the United States for long-term use as an appetite suppressant until it was reported to be associated with valvular heart disease. The valvular changes (myofibroblast proliferation) are histopathologically indistinguishable from those observed in carcinoid disease or after long-term exposure to 5-hydroxytryptamine (5-HT)(2)-preferring ergot drugs (ergotamine, methysergide). 5-HT(2) receptor stimulation is known to cause fibroblast mitogenesis, which could contribute to this lesion. To elucidate the mechanism of "fen-phen"-associated valvular lesions, we examined the interaction of fenfluramine and its metabolite norfenfluramine with 5-HT(2) receptor subtypes and examined the expression of these receptors in human and porcine heart valves. Fenfluramine binds weakly to 5-HT(2A), 5-HT(2B), and 5-HT(2C) receptors. In contrast, norfenfluramine exhibited high affinity for 5-HT(2B) and 5-HT(2C) receptors and more moderate affinity for 5-HT(2A) receptors. In cells expressing recombinant 5-HT(2B) receptors, norfenfluramine potently stimulated the hydrolysis of inositol phosphates, increased intracellular Ca(2+), and activated the mitogen-activated protein kinase cascade, the latter of which has been linked to mitogenic actions of the 5-HT(2B) receptor. The level of 5-HT(2B) and 5-HT(2A) receptor transcripts in heart valves was at least 300-fold higher than the levels of 5-HT(2C) receptor transcript, which were barely detectable. We propose that preferential stimulation of valvular 5-HT(2B) receptors by norfenfluramine, ergot drugs, or 5-HT released from carcinoid tumors (with or without accompanying 5-HT(2A) receptor activation) may contribute to valvular fibroplasia in humans.

[1]  L. Kaminsky,et al.  Optimization of Dnase I removal of contaminating DNA from RNA for use in quantitative RNA-PCR. , 1996, BioTechniques.

[2]  R. Mayer,et al.  Medical progress : Carcinoid tumors , 1999 .

[3]  T. Jessell,et al.  Ectopic expression of the serotonin 1c receptor and the triggering of malignant transformation. , 1989, Science.

[4]  C. Tapparelli,et al.  Methylergometrine, an Active Metabolite of Methysergide , 1986, Cephalalgia : an international journal of headache.

[5]  N. Newberry,et al.  Characterisation of Human 5‐Hydroxytryptamine2A and 5‐Hydroxytryptamine2C Receptors Expressed in the Human Neuroblastoma Cell Line SH‐SY5Y: Comparative Stimulation by Hallucinogenic Drugs , 1996, Journal of neurochemistry.

[6]  A. Probst,et al.  Activation of Meningeal 5‐HT2B Receptors: An Early Step in the Generation of Migraine Headache? , 1996, The European journal of neuroscience.

[7]  W. Edwards,et al.  Valvular heart disease associated with fenfluramine-phentermine. , 1997, The New England journal of medicine.

[8]  S. Erban,et al.  Risk for Valvular Heart Disease among Users of Fenfluramine and Dexfenfluramine Who Underwent Echocardiography before Use of Medication , 1998, Annals of Internal Medicine.

[9]  S. Garattini,et al.  Disposition of (-)-fenfluramine and its active metabolite, (-)-norfenfluramine in rat: a single dose-proportionality study. , 1988, Xenobiotica; the fate of foreign compounds in biological systems.

[10]  J. Launay,et al.  Ras Involvement in Signal Transduction by the Serotonin 5-HT2B Receptor (*) , 1996, The Journal of Biological Chemistry.

[11]  E. Gibson,et al.  Appetite suppression by commonly used drugs depends on 5-HT receptors but not on 5-HT availability. , 1997, TIPS - Trends in Pharmacological Sciences.

[12]  M. Lopez-Ilasaca.  Signaling from G-protein-coupled receptors to mitogen-activated protein (MAP)-kinase cascades. , 1998, Biochemical pharmacology.

[13]  L. Phebus,et al.  Serotonin in migraine: theories, animal models and emerging therapies. , 1998, Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques.

[14]  H. Lübbert,et al.  Expression of serotonin receptor mRNAs in blood vessels , 1995, FEBS letters.

[15]  O. Kellermann,et al.  Mouse 5‐HT2B Receptor‐mediated Serotonin Trophic Functions a , 1998, Annals of the New York Academy of Sciences.

[16]  C. Heid,et al.  A novel method for real time quantitative RT-PCR. , 1996, Genome research.

[17]  L. G. Davis,et al.  Basic methods in molecular biology , 1986 .

[18]  D. Nelson,et al.  Molecular cloning, functional expression, and pharmacological characterization of a novel serotonin receptor (5-hydroxytryptamine2F) from rat stomach fundus. , 1992, Molecular pharmacology.

[19]  B. Largent,et al.  High‐Affinity Agonist Binding Correlates with Efficacy (Intrinsic Activity) at the Human Serotonin 5‐HT2A and 5‐HT2C Receptors: Evidence Favoring the Ternary Complex and Two‐State Models of Agonist Action , 1999, Journal of neurochemistry.